FDA updates
Gadolinium MRI Poisoning Investigation
The FDA issued a safety alert in December 2017, stating that some patients who received a gadolinium-based contrast during an MRI procedure, may retain the gadolinium in their bodies for months, or even for years, causing serious side effects. Gadolinium is commonly used in MRIs to enhance the images the test provides. Gadolinium is a...
more →
FDA recalls Valsartan – Antihypertensive drug
Valsartan is mainly used for treatment of high blood pressure, congestive heart failure, and after a heart attack. The FDA has announced a recall of several drugs that contain the heart drug valsartan because a possible carcinogen NDMA (N-Nitrosodimethylamine) that was found in the recalled products. NDMA, which was found in the valsartan products, could...
more →
Fluoroquinolone Antibiotics are linked to Mental Health Side Effects
FDA posted a label changes request for FLQ on July 10th of 2018. FLQs such as Levaquin, Cipro, Avelox and others can cause the following side effects: disturbances in attention disorientation agitation nervousness memory impairment serious disturbances in mental abilities called delirium. “FDA is strengthening the current warnings in the prescribing information that fluoroquinolone antibiotics...
more →
FDA Now Regulates E-Cigarettes and Vaporizers
FDA’s Deeming Regulations for E-Cigarettes, Cigars, and All Other Tobacco Products. Mitch Zeller, Director of FDA’s Center for Tobacco Products posted in his blog that It will become illegal nationwide to sell cigars, hookah tobacco, and e-cigarettes to anyone under age 18 and retailers will need to check photo ID of anyone under age 27....
more →